Paying for cost-effective health care: Does it violate both static- and dynamic efficiency?
Nordic Journal of Health Economics, 2015 Recent research has questioned the rationales of using cost-effectiveness metrics of medical technologies to guide reimbursement. I discuss here the underlying ideas of this research, which argues that reimbursement based on cost effectiveness criteria ...
Tomas J Philipson
doaj +1 more source
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease [PDF]
, 2002 When choosing between mutually exclusive treatment options, it is common to construct a cost-effectiveness frontier on the cost-effectiveness plane that represents efficient points from among the treatment choices.
Goeree, R. +7 more
core +1 more source
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
Molecular Oncology, EarlyView.LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir +9 more
wiley +1 more source
PDG13 COST†EFFECTIVENESS ANALYSIS OF DEXMETOMIDINE COMPARED WITH PROPOFOL AND MIDAZOLAM FOR MECHANICALLY VENTILATED ADULT PATIENTS IN COLOMBIA [PDF]
Value in Health, 2019 N. Castaño Gamboa, J. Reyes, F. Ruiz
openaire +1 more source
Cost and cost-effectiveness guidelines: which ones to use? [PDF]
, 2001 Given the increased awareness of the importance of cost-effectiveness in health care, there has been a growth in the number of published economic evaluations in recent years.
Walker, D
core +1 more source
Molecular Oncology, EarlyView.This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan +8 more
wiley +1 more source
Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS)
Cost Effectiveness and Resource AllocationBackground Treatment cost and high prevalence of Poly Cystic Ovarian Syndrome (PCOS) is a very challenging issue globally. Due to this reason; current study was conducted to determine pharmaco-economy of conventional and non-conventional treatments for ...
Darakhshan Masroor +4 more
doaj +1 more source
Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis [PDF]
, 2002 <b>Objective</b>: To compare the cost and cost-effectiveness of a policy of pre-operative optimisation of oxygen delivery (using either adrenaline or dopexamine) to reduce the risk associated with major elective surgery, in high-risk patients.
Sculpher, M.J. +3 more
core +1 more source
Cost-effectiveness acceptability curves from probabilistic sensitivity analysis.
, 2023 Cost-effectiveness acceptability curves from probabilistic sensitivity analysis.
Coline Dubois de Gennes (14445446) +6 more
core +1 more source
Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma
Molecular Oncology, EarlyView.Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara +10 more
wiley +1 more source